1 [12] . Risk is also conferred by various non-MHC background genes [13] . As judged from IDDM-specific serum autoantibodies [14] , the major autoantigens of the beta cell include glutamic acid decarboxylase (GAD) [15, 16] , insulin [17] , and a molecule called islet cell antigen 512 [18, 19] or IA-2 [20] , which is probably a protein tyrosine phosphatase corresponding to the 37/40 kDa autoantigen [21, 22] . Overall, anti-GAD is the most frequent autoimmune reactivity in IDDM [15, 23] , and, together with anti-ICA512, accounts for most of the islet cell antibodies (ICA) demonstrable by immunofluorescence [19] . Anti-GAD is also claimed to be the earliest antibody generated, at least in non-obese diabetic (NOD) mice [24] .
Various hypotheses have been proposed regarding the provocation of the autoimmune process leading to IDDM in the high-risk genotype. One favoured idea is based on molecular mimicry [1, 23, 25, 26] whereby the critical event is infection with a virus or micro-organism that displays to the immune system a protein resembling a constituent of the body sufficiently closely so that the response is cross-reactive with an autologous molecule (self). The coxsackie B4 virus has been particularly incriminated in IDDM, according to seasonality of the disease onset; sequence similarity between GAD and virus proteins [1, 23, 25] ; identification of viral sequences in serum of children at onset of disease [27] ; and a high frequency of serological evidence of enterovirus exposure both in utero and in childhood [28] . On the other hand, the concept of molecular mimicry is not sustained by the failure of monoclonal antibodies to recognize sequences of GAD [29] , nor does it explain why autoimmune responses to GAD specifically occur in beta cells. Thus, even if enterovirus infections were relevant to the pathogenesis of IDDM, mechanisms other than molecular mimicry could be involved.
We suggest that the pathogenesis of IDDM depends on an immunological response to a critical natural autoantigen that is up-regulated and abnormally presented to the immune system by metabolic alterations or islet cell damage. This idea has been considered previously [30] , but has not been developed as a credible alternative to molecular mimicry. Here we describe biochemical pathways for the metabolic induction and up-regulation of the autoantigen GAD, and how this might sustain the specific autoimmune destruction of beta cells and the eventual development of IDDM. These pathways depend critically on mitochondrial oxidative phosphorylation (oxphos), and include key metabolic interactions of g -aminobutyric acid (GABA) that we designate the GABA network of the beta cell.
Critical effects of oxidative phosphorylation deficiency
Islet cells have many similarities to neurons [30, 31] , one being their high energy dependence on mitochondrial oxphos [31] . In particular, beta cells require mitochondrial ATP to sustain the production and release of insulin [31] [32] [33] [34] . Indeed, the increase of intracellular ATP which is stimulated by a high blood glucose level is the signal for insulin release via a block of potassium channels in the plasma membrane of the beta cells [32] [33] [34] . The critical role of oxphos in providing this ATP signalling is clearly illustrated by the high susceptibility of beta cells to energy deficits consequent to mitochondrial gene mutations [3, 4] , now recognized as the disease entity 'mitochondrial diabetes' [4] . We consider that various toxins, febrile states or even sugar overload can induce a deficiency in mitochondrial oxphos similar to that resulting from inherited mutations, albeit only transiently. This environmentally induced oxphos deficiency will then perturb the GABA network of beta cells.
Perturbation of the GABA network
The GABA network of the beta cell describes crucial biochemical pathways, central to which is the neurotransmitter GABA, itself the product of the catalytic activity of GAD. As mentioned, beta cells resemble neurons in many respects [30, 31] , including their strict dependence on oxphos and also the high content GABA of which they secrete via synapticlike microvesicles [35, 36] . The increased ATP levels produced by accelerated oxphos in response to high blood glucose levels not only promote insulin release [32] [33] [34] , but also facilitate the accumulation of GABA into synaptic-like microvesicles and its subsequent release within the islets [35, 36] . This release of GABA fulfills the crucial paracrine function of fine regulation of the secretion of other islet cell hormones, especially glucagon [37] (Fig. 1 ). Since all of the ATP in beta cells is produced by mitochondrial oxphos [31] , the endocrine function of insulin secretion, and the paracrine function of GABA secretion, are both strictly dependent on full functional activity of mitochondrial oxphos.
In addition, the GABA network and oxphos are intimately connected in the beta cells by a mitochondrial enzyme, GABA transaminase [38], which directs the catabolism of GABA to produce succinate. Succinate then enters the tricarboxylic acid (TCA) cycle and is directly oxidized by the mitochondrial respiratory chain [38, 39] . The mitochondrial catabolism of GABA, known as the GABA shunt [38], can generate succinate while removing a -ketoglutarate, thus effectively bypassing the dehydrogenases of the TCA cycle, in particular isocitrate dehydrogenase, which are inhibited by high levels of ATP. This bypass could be critical for sustaining the preferential activation of mitochondrial oxphos during a glucose stimulus for insulin release [31] [32] [33] [34] 38] , and would need to be strictly regulated within the beta cells to maintain an optimal equilibrium between GABA catabolism and GABA release for paracrine signalling (Fig. 1) .
Given that the activity of GAD is the rate-limiting step of the GABA shunt [39] , GAD can be seen as the key enzyme of the GABA network, to maintain insulin secretion in response to blood glucose and the paracrine function of GABA within the islets (Fig. 1) . Consequently, beta cells must compensate Mitochondrial oxidative phosphorylation, the GABA network and up-regulation of GAD in beta cells. The betacell subserves insulin release, and secretion of GABA via the synaptic-like-microvesicles (SLMV), to modulate the secretion of glucagon by alpha cells. These activities depend on GABA and ATP, requiring full functional activity of mitochondrial oxidative phosphorylation (oxphos). Oxphos provides ATP for insulin release and for transporting GABA into the SLMV by a proton-ATPase. GAD65, the predominant and antigenic form of GAD, is bound to these vesicles and thereby transferred to the plasma membrane by exocytosis with release of GABA. Metabolic perturbation of the GABA network, e. g. by impairment of oxphos, leads to up-regulation of GAD and its increased expression at the cell surface via vesicle traffic and exocytosis for any perturbation in the GABA network by controlling the activity of GAD. Finally, the resemblance between beta cells and neurons prompts reference to studies on oxidative damage to the brain, e. g. hypoxia [40] , wherein the expression and activity of GAD increase in response to the ensuing excess of glutamate that results from impaired mitochondrial respiration. Glutamate inevitably accumulates in cells with a defective respiratory chain because NADH produced in mitochondria cannot be re-oxidized and, consequently, the equilibrium of glutamate dehydrogenase is shifted towards the production of glutamate. Accordingly, in beta cells as in the brain, febrile, hypoxic or environmental toxic stresses would be prejudicial to mitochondrial bioenergetic functions, and to GABA metabolism. The result is over-production of GAD within the cell.
Perturbation of the GABA network in the pathogenesis of IDDM
The concept central to our proposition is that beta cells respond to an excess glutamate accumulation, of toxic, metabolic or other origin, with an over-expression of GAD. This up-regulation would also coordinately maintain the high levels of GABA required for both its energetic [38, 39] and paracrine functions. In turn, over-expression of GAD will influence the cellular traffic of synaptic-like microvesicles, and so result in an increased extracellular presentation of GAD65, the prevalent isoform of GAD in human beta cells which is associated with synaptic-like microvesicles [15, 23, 35] (Fig. 1) .
This enhanced intracellular expression of GAD, and its presumed presentation at the beta-cell surface, will perturb tolerance to it in individuals with particular genotypes, and thus initiate the autoimmune cascade leading to IDDM. Supporting this, studies on animal models of IDDM suggest that a link exists between the metabolic state of beta cells and their expression of cell surface antigens [1, 41] . Indeed, in NOD mice anti-GAD is the first of several autoantigenic responses [24] , and there is also an increased islet cell expression of GAD and GABA [42] . Thus, in mice as in humans, the metabolic link could be provided by the GABA network and its regulation to preserve paracrine function in the islets.
The steps from over-expression of the GAD autoantigen to the immunological initiation of destructive insulitis remain hypothetical. It should be considered how GAD, or other islet cell autoantigens, enter the requisite pathways for presentation by MHC molecules to T lymphocytes. Presumably, the high-risk genotype will allow for the presence in peripheral tissues of T lymphocytes with a capability for reactivity with appropriately expressed epitopes of GAD. Intracellular over-expression of GAD could, in the predisposing genotype, result in efficient presentation of GAD fragments at the cell surface through the class I pathway and engagement of CD8 cytotoxic T lymphocytes, as shown in the NOD mouse [43] . Alternatively, promiscuous extracellular presentation of GAD, or incidental accompanying damage to beta cells with release of intracellular GAD, could allow for the uptake of GAD by the macrophage-dendritic types of antigen-presenting cells normally present within the islets [44] , and their presentation of autoantigenic moieties to CD4 T lymphocytes. We note that prominence of macrophage-type cells in islets is one of the earliest features of the insulitis lesion of IDDM [44, 45] . Once CD4 or CD8 T cells with specificity for GAD are recruited to the islets, the stage is set for an influx of other immune inflammatory cell types and activation of downstream events including release of cytokines characteristic of inflammatory autoimmune responses [1, 46] .
The steps whereby beta cells become specific targets for GAD autoimmunity are shown in Figure 2 . One or more defects in the energy and glutamate metabolism in beta cells would induce an over-expression of GAD. This would also increase the breakdown of GAD and the recycling of its degradation fragments, thus overloading the MHC system and creating the conditions for T-cell recognition and Figure 1 , and the lower section itemizes the immunological steps that lead to insulitis and IDDM autoimmune insulitis targeted at beta cells that culminates in IDDM. Thus, a perturbation of the GABA network results in an enhanced presentation of potentially immunogenic GAD at the surface of beta cells.
Wider implications of metabolic induction of IDDM
The recent discovery that the rodenticide Vacor, a potent environmental inducer of IDDM in humans, specifically inhibits mitochondrial respiration [47] provides further evidence in support of the concept that mitochondrial malfunction can be relevant to the pathogenesis of diabetes. Our proposition of a metabolic induction of IDDM by toxic exposure or nutrient stress would explain the 'random' component in disease susceptibility [1] , as well as having wider implications for the induction of autoimmunity in general, together with important practical connotations. In particular, the increased incidence of IDDM in recent decades with its apparent correlation with changing dietary habits, including excessive loads of sugars and amino acids [1] , readily fits in with our proposal. Additionally, the cellular level of critical autoantigens has been suggested to influence the expression of autoimmune diseases including IDDM [1] , since when such an expression is alleviated there is a well-recognized beneficial effect, initially called "beta-cell rest" [48] , which has been recently validated experimentally [41, 49] . In the context of our ideas, this effect could be rationalized as a result of exogenously induced relief of metabolic stress on beta cells under the 'pressure' of high blood glucose in individuals with an imbalanced GABA network. This concept has also been applied to the treatment of autoimmune hyperthyroidism by thyroxine to reduce thyroid antigen release [50] .
Finally, dietary deficiency of crucial amino acids is believed to contribute to the pathogenesis of non-insulin-dependent diabetes mellitus (NIDDM) [51] , and the present proposal could provide a biochemical rationale to link the metabolism of the central amino acid glutamate to the unique cellular activity of pancreatic beta cells.
Conclusions
The GABA network concept could represent a unifying scheme for key metabolic defects relevant to IDDM and also to some types of NIDDM including mitochondrial diabetes [4] . In fact, the essential difference between IDDM and such types of NIDDM could simply be the superimposition of the autoimmune response, itself linked to multiple genetic elements, which accelerates the destruction of the beta cells. The state sufficient for IDDM pathogenesis is a susceptible genotype and an overproduction of an intrinsic autoantigen, GAD, as a consequence of abnormalities in crucial metabolic pathways that are specific to the beta cells of pancreatic islets, the GABA network. This conclusion may encourage further debate.
